Affinity maturation and characterization of the ofatumumab monoclonal antibody
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Affinity maturation and characterization of the ofatumumab monoclonal antibody
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-08-31
DOI
10.1002/jcb.27457
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of a novel single chain fragment variable antibody targeting CD24-expressing cancer cells
- (2017) Shirin Eyvazi et al. IMMUNOLOGY LETTERS
- Advances in Antibody Design
- (2015) Kathryn E. Tiller et al. Annual Review of Biomedical Engineering
- Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins
- (2015) Pietro Sormanni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional Mutations in and Characterization of VHH Against Helicobacter pylori Urease
- (2014) Reyhaneh Hoseinpoor et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- OptMAVEn – A New Framework for the de novo Design of Antibody Variable Region Models Targeting Specific Antigen Epitopes
- (2014) Tong Li et al. PLoS One
- Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii
- (2014) Z. Payandeh et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Ofatumumab: a novel, fully human anti-CD20 monoclonal antibody for the treatment of chronic lymphocytic leukemia
- (2013) Matthew J Barth et al. Future Oncology
- Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns
- (2012) A. Schuh et al. BLOOD
- The clinical application of monoclonal antibodies in chronic lymphocytic leukemia
- (2010) S. M. Jaglowski et al. BLOOD
- Targeting protein–protein interactions for therapeutic intervention: a challenge for the future
- (2010) Giovanna Zinzalla et al. Future Medicinal Chemistry
- Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia
- (2010) Tadeusz Robak et al. JOURNAL OF CLINICAL ONCOLOGY
- A Simple Definition of Structural Regions in Proteins and Its Use in Analyzing Interface Evolution
- (2010) Emmanuel D. Levy JOURNAL OF MOLECULAR BIOLOGY
- Development trends for human monoclonal antibody therapeutics
- (2010) Aaron L. Nelson et al. NATURE REVIEWS DRUG DISCOVERY
- CD20 deficiency in humans results in impaired T cell–independent antibody responses
- (2009) Taco W. Kuijpers et al. JOURNAL OF CLINICAL INVESTIGATION
- Binding of Submaximal C1q Promotes Complement-Dependent Cytotoxicity (CDC) of B Cells Opsonized with Anti-CD20 mAbs Ofatumumab (OFA) or Rituximab (RTX): Considerably Higher Levels of CDC Are Induced by OFA than by RTX
- (2009) A. W. Pawluczkowycz et al. JOURNAL OF IMMUNOLOGY
- Purine-Rich Box-1-Mediated Reduced Expression of CD20 Alters Rituximab-Induced Lysis of Chronic Lymphocytic Leukemia B Cells
- (2008) A. Mankai et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation